Adapttech
Adapttech, now operating as Amparo, develops smart prosthetic technology for orthopedic rehabilitation, providing an innovative prosthetic socket system that enables clinicians to fit amputees with functional prostheses in one to two hours. The Amparo System features thermoplastic sockets that are fully remoldable, requiring only one socket for up to five fittings, and can be fitted anywhere without specialist…
Funding snapshot
About
Adapttech, now operating as Amparo, develops smart prosthetic technology for orthopedic rehabilitation, providing an innovative prosthetic socket system that enables clinicians to fit amputees with functional prostheses in one to two hours. The Amparo System features thermoplastic sockets that are fully remoldable, requiring only one socket for up to five fittings, and can be fitted anywhere without specialist machinery. The system includes the Majicast for weight-bearing shape capture, the Resilience Socket, suspension units, tools, and accessories. The company also offers Motio Functional Reports, a wearable device service that tracks lower limb prosthetic users' daily activities for a minimum of seven days, providing rehabilitation teams with data to make informed decisions about prosthetic rehabilitation. Founded in 2015 and headquartered in Porto, Portugal, the company has raised approximately $7.4M in Series A funding. Adapttech differentiates itself through its mobile, all-in-one system that enables immediate rehabilitation without prolonged interruption, with pre-assembled components streamlining the fabrication process.
Business model
Wearable Technology > Health and Wellness Devices > Rehabilitation,
Assistive Tech > Assistive Hardware > Mobility > Prostheses,
Orthopedics > Medical Devices > Therapies > Rehabilitation
Team background
College Wise > Carnegie Mellon University
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.